Oral Pharmabiotic Tablet Formulations

dc.contributor.author Kandur, Buse
dc.contributor.author Ugurlu, Timucin
dc.contributor.author Rayaman, Erkan
dc.contributor.author Ahbaz, Sevinc S.
dc.date.accessioned 2025-01-11T13:04:25Z
dc.date.available 2025-01-11T13:04:25Z
dc.date.issued 2024
dc.description.abstract Pharmabiotic is a unique and recent term used to describe formulations containing probiotics. Pharmabiotics are probiotics prepared in a pharmaceutical form used to treat diseases and disorders by making physicochemical changes in human health. Probiotics, prebiotics, and synbiotics are included in this scope, and enzobiotics, which are a rising class of supplements, should be evaluated in this context, as they are a subspecies of synbiotics. Pharmabiotics, unlike nutribiotics, do not necessarily contain live microorganisms. The best examples of these are paraprobiotics and postbiotics. Tablet formulations are suitable dosage forms for pharmabiotics due to their redundant superiority over other solid dosage forms. Tablets are frequently preferred because they can be produced at low cost, are easily transported, and modified, are suitable for large-scale production, and are more stable than other dosage forms. Considering the examples in the literature and the definition of pharmabiotic, several tablet formulations can be mentioned as pharmabiotics. They can be divided into conventional uncoated tablets, chewable tablets, and effervescent tablets. With recent studies, this classification has expanded, and buccal mucoadhesive tablets, ODTs (orally disintegrating tablets) and FDTs (fast disintegrating tablets), layered/multi-layered tablets, and tablets within tablets have also taken their place in the classification. This article focuses on oral tablet formulations that can be classified as pharmabiotics. en_US
dc.identifier.citation 0
dc.identifier.doi 10.29228/jrp.691
dc.identifier.issn 2630-6344
dc.identifier.scopus 2-s2.0-85185511579
dc.identifier.uri https://doi.org/10.29228/jrp.691
dc.identifier.uri https://hdl.handle.net/20.500.14627/364
dc.language.iso en en_US
dc.publisher Marmara Univ en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Pharmabiotic en_US
dc.subject Probiotic en_US
dc.subject Prebiotic en_US
dc.subject Types Of Tablets en_US
dc.subject Formulation en_US
dc.title Oral Pharmabiotic Tablet Formulations en_US
dc.type Review en_US
dspace.entity.type Publication
gdc.author.scopusid 58896055500
gdc.author.scopusid 16647911100
gdc.author.scopusid 8889406300
gdc.author.scopusid 42462319400
gdc.description.department Fenerbahçe University en_US
gdc.description.departmenttemp [Kandur, Buse] Fenerbahce Univ, Fac Pharm, Dept Pharmaceut Technol, TR-34758 Istanbul, Turkiye; [Kandur, Buse] Marmara Univ, Inst Hlth Sci, Dept Pharmaceut Technol, TR-34865 Istanbul, Turkiye; [Ugurlu, Timucin; Ahbaz, Sevinc S.] Marmara Univ, Fac Pharm, Dept Pharmaceut Technol, TR-34854 Istanbul, Turkiye; [Rayaman, Erkan] Marmara Univ, Fac Pharm, Dept Pharmaceut Microbiol, TR-34854 Istanbul, Turkiye en_US
gdc.description.endpage 247 en_US
gdc.description.issue 1 en_US
gdc.description.publicationcategory Diğer en_US
gdc.description.scopusquality Q4
gdc.description.startpage 236 en_US
gdc.description.volume 28 en_US
gdc.description.woscitationindex Emerging Sources Citation Index
gdc.identifier.wos WOS:001167297700008
gdc.scopus.citedcount 2
gdc.wos.citedcount 1

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
48e0df28-aa91-4dc8-aea6-4ebc6217314d.pdf
Size:
548.24 KB
Format:
Adobe Portable Document Format